Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tango Therapeutics Inc (TNGX)

Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tango Therapeutics Inc 201 BROOKLINE AVE. SUITE 901 BOSTON MA 02215 USA

www.tangotx.com Employees: 140 P: 857-320-4900

Description:

Tango Therapeutics Inc. is a biotechnology company. It focused on discovering and delivering precision cancer medicines. Tango Therapeutics Inc., formerly known as BCTG Acquisition Corp., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 421,079
Enterprise Value, $K 353,839
Shares Outstanding, K 107,418
Annual Sales, $ 36,530 K
Annual Net Income, $ -101,740 K
Last Quarter Sales, $ 11,610 K
Last Quarter Net Income, $ -29,170 K
EBIT, $ -139,700 K
EBITDA, $ -140,680 K
60-Month Beta 0.88
% of Insider Shareholders 6.30%
% of Institutional Shareholders 78.99%
Float, K 100,651
% Float 93.70%
Short Volume Ratio 0.52

Growth:

1-Year Return -45.27%
3-Year Return -67.25%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 11/06/24
Next Earnings Date 11/13/24
Earnings Per Share ttm -1.18
EPS Growth vs. Prev Qtr -12.50%
EPS Growth vs. Prev Year -17.39%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TNGX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -49.64%
Return-on-Assets % -32.00%
Profit Margin % -278.51%
Debt/Equity 0.00
Price/Sales 10.47
Price/Cash Flow N/A
Price/Book 1.66
Book Value/Share 2.14
Interest Coverage -1.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar